Cargando…

Neuroinflammation and amyloid-beta 40 are associated with reduced serotonin transporter (SERT) activity in a transgenic model of familial Alzheimer’s disease

BACKGROUND: Discrepant and often contradictory results have accumulated regarding the antidepressant and pro-cognitive effects of serotonin transporter (SERT) antagonists in Alzheimer’s disease. METHODS: To address the discrepancy, we measured the activity and density of SERT in the neocortex of 3–2...

Descripción completa

Detalles Bibliográficos
Autores principales: Metaxas, Athanasios, Anzalone, Marco, Vaitheeswaran, Ramanan, Petersen, Sussanne, Landau, Anne M., Finsen, Bente
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6495598/
https://www.ncbi.nlm.nih.gov/pubmed/31043179
http://dx.doi.org/10.1186/s13195-019-0491-2
_version_ 1783415367804125184
author Metaxas, Athanasios
Anzalone, Marco
Vaitheeswaran, Ramanan
Petersen, Sussanne
Landau, Anne M.
Finsen, Bente
author_facet Metaxas, Athanasios
Anzalone, Marco
Vaitheeswaran, Ramanan
Petersen, Sussanne
Landau, Anne M.
Finsen, Bente
author_sort Metaxas, Athanasios
collection PubMed
description BACKGROUND: Discrepant and often contradictory results have accumulated regarding the antidepressant and pro-cognitive effects of serotonin transporter (SERT) antagonists in Alzheimer’s disease. METHODS: To address the discrepancy, we measured the activity and density of SERT in the neocortex of 3–24-month-old APP(swe)/PS1(dE9) and wild-type littermate mice, by using [(3)H]DASB autoradiography and the [(3)H]5-HT uptake assay. Levels of soluble amyloid-β (Aβ), and pro-inflammatory cytokines that can regulate SERT function, such as interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor (TNF), were measured in parallel. Neuroinflammation in aging APP(swe)/PS1(dE9) mice was further evaluated by [(3)H]PK11195 autoradiography. RESULTS: Decreased SERT density was observed in the parietal and frontal cortex of 18–24-month-old APP(swe)/PS1(dE9) mice, compared to age-matched, wild-type animals. The maximal velocity uptake rate (V(max)) of [(3)H]5-HT was reduced in neocortical preparations from 20-month-old transgenic vs. wild-type mice. The reduction was observed when the proportion of soluble Aβ(40) in the Aβ(40/42) ratio increased in the aged transgenic brain. At concentrations compatible with those measured in 20-month-old APP(swe)/PS1(dE9) mice, synthetic human Aβ(40), but not Aβ(42), reduced the baseline V(max) of [(3)H]5-HT by ~ 20%. Neuroinflammation in APP(swe)/PS1(dE9) vs. wild-type mice was evidenced by elevated [(3)H]PK11195 binding levels and increased concentration of IL-1β protein, which preceded the reductions in neocortical SERT density and activity. Age-induced increases in the levels of IL-1β, IL-6, and TNF were observed in both transgenic and wild-type animals. CONCLUSIONS: The progression of cerebral amyloidosis is associated with neuroinflammation and decreased presynaptic markers of serotonergic integrity and activity. The Aβ(40)-induced reduction in the uptake kinetics of [(3)H]5-HT suggests that the activity of SERT, and potentially the effects of SERT antagonism, depend on the levels of interstitial Aβ(40).
format Online
Article
Text
id pubmed-6495598
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64955982019-05-08 Neuroinflammation and amyloid-beta 40 are associated with reduced serotonin transporter (SERT) activity in a transgenic model of familial Alzheimer’s disease Metaxas, Athanasios Anzalone, Marco Vaitheeswaran, Ramanan Petersen, Sussanne Landau, Anne M. Finsen, Bente Alzheimers Res Ther Research BACKGROUND: Discrepant and often contradictory results have accumulated regarding the antidepressant and pro-cognitive effects of serotonin transporter (SERT) antagonists in Alzheimer’s disease. METHODS: To address the discrepancy, we measured the activity and density of SERT in the neocortex of 3–24-month-old APP(swe)/PS1(dE9) and wild-type littermate mice, by using [(3)H]DASB autoradiography and the [(3)H]5-HT uptake assay. Levels of soluble amyloid-β (Aβ), and pro-inflammatory cytokines that can regulate SERT function, such as interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor (TNF), were measured in parallel. Neuroinflammation in aging APP(swe)/PS1(dE9) mice was further evaluated by [(3)H]PK11195 autoradiography. RESULTS: Decreased SERT density was observed in the parietal and frontal cortex of 18–24-month-old APP(swe)/PS1(dE9) mice, compared to age-matched, wild-type animals. The maximal velocity uptake rate (V(max)) of [(3)H]5-HT was reduced in neocortical preparations from 20-month-old transgenic vs. wild-type mice. The reduction was observed when the proportion of soluble Aβ(40) in the Aβ(40/42) ratio increased in the aged transgenic brain. At concentrations compatible with those measured in 20-month-old APP(swe)/PS1(dE9) mice, synthetic human Aβ(40), but not Aβ(42), reduced the baseline V(max) of [(3)H]5-HT by ~ 20%. Neuroinflammation in APP(swe)/PS1(dE9) vs. wild-type mice was evidenced by elevated [(3)H]PK11195 binding levels and increased concentration of IL-1β protein, which preceded the reductions in neocortical SERT density and activity. Age-induced increases in the levels of IL-1β, IL-6, and TNF were observed in both transgenic and wild-type animals. CONCLUSIONS: The progression of cerebral amyloidosis is associated with neuroinflammation and decreased presynaptic markers of serotonergic integrity and activity. The Aβ(40)-induced reduction in the uptake kinetics of [(3)H]5-HT suggests that the activity of SERT, and potentially the effects of SERT antagonism, depend on the levels of interstitial Aβ(40). BioMed Central 2019-05-01 /pmc/articles/PMC6495598/ /pubmed/31043179 http://dx.doi.org/10.1186/s13195-019-0491-2 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Metaxas, Athanasios
Anzalone, Marco
Vaitheeswaran, Ramanan
Petersen, Sussanne
Landau, Anne M.
Finsen, Bente
Neuroinflammation and amyloid-beta 40 are associated with reduced serotonin transporter (SERT) activity in a transgenic model of familial Alzheimer’s disease
title Neuroinflammation and amyloid-beta 40 are associated with reduced serotonin transporter (SERT) activity in a transgenic model of familial Alzheimer’s disease
title_full Neuroinflammation and amyloid-beta 40 are associated with reduced serotonin transporter (SERT) activity in a transgenic model of familial Alzheimer’s disease
title_fullStr Neuroinflammation and amyloid-beta 40 are associated with reduced serotonin transporter (SERT) activity in a transgenic model of familial Alzheimer’s disease
title_full_unstemmed Neuroinflammation and amyloid-beta 40 are associated with reduced serotonin transporter (SERT) activity in a transgenic model of familial Alzheimer’s disease
title_short Neuroinflammation and amyloid-beta 40 are associated with reduced serotonin transporter (SERT) activity in a transgenic model of familial Alzheimer’s disease
title_sort neuroinflammation and amyloid-beta 40 are associated with reduced serotonin transporter (sert) activity in a transgenic model of familial alzheimer’s disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6495598/
https://www.ncbi.nlm.nih.gov/pubmed/31043179
http://dx.doi.org/10.1186/s13195-019-0491-2
work_keys_str_mv AT metaxasathanasios neuroinflammationandamyloidbeta40areassociatedwithreducedserotonintransportersertactivityinatransgenicmodeloffamilialalzheimersdisease
AT anzalonemarco neuroinflammationandamyloidbeta40areassociatedwithreducedserotonintransportersertactivityinatransgenicmodeloffamilialalzheimersdisease
AT vaitheeswaranramanan neuroinflammationandamyloidbeta40areassociatedwithreducedserotonintransportersertactivityinatransgenicmodeloffamilialalzheimersdisease
AT petersensussanne neuroinflammationandamyloidbeta40areassociatedwithreducedserotonintransportersertactivityinatransgenicmodeloffamilialalzheimersdisease
AT landauannem neuroinflammationandamyloidbeta40areassociatedwithreducedserotonintransportersertactivityinatransgenicmodeloffamilialalzheimersdisease
AT finsenbente neuroinflammationandamyloidbeta40areassociatedwithreducedserotonintransportersertactivityinatransgenicmodeloffamilialalzheimersdisease